Blood serum microRNA biomarkers for oesophageal cancer

食管腺癌(OAC)是西方世界第六常见的癌症死亡原因，而且发病率正在上升。在澳大利亚，大多数患者来晚了，需要高风险的治疗，治愈率很低。出现早和晚的个体在存活率上有很大的差异。早期发现癌症或发现癌症前期的更好方法将改善结果。我们的研究将开发一种血液测试来识别早期OAC患者，以便更早地进行治疗。

Oesophageal adenocarcinoma (OAC) is the 6th commonest cause of cancer deaths in the Western World, and is increasing in incidence. In Australia most patients present late and require risky treatments with a low cure rate. There is a big difference in survival between individuals presenting early vs. late. Better methods to detect cancer early or detect pre-cancer will improve outcomes. Our research will develop a blood test for identifying individuals with early OAC to allow earlier treatment.